ATE336246T1 - Verfahren zur behandlung von neurodegeneration - Google Patents

Verfahren zur behandlung von neurodegeneration

Info

Publication number
ATE336246T1
ATE336246T1 AT01906242T AT01906242T ATE336246T1 AT E336246 T1 ATE336246 T1 AT E336246T1 AT 01906242 T AT01906242 T AT 01906242T AT 01906242 T AT01906242 T AT 01906242T AT E336246 T1 ATE336246 T1 AT E336246T1
Authority
AT
Austria
Prior art keywords
treating neurodegeneration
neurodegeneration
treating
Prior art date
Application number
AT01906242T
Other languages
German (de)
English (en)
Inventor
Eiichi Otomo
Y Takasu
Original Assignee
Hamilton Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hamilton Pharmaceuticals Inc filed Critical Hamilton Pharmaceuticals Inc
Application granted granted Critical
Publication of ATE336246T1 publication Critical patent/ATE336246T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
AT01906242T 2000-02-23 2001-02-23 Verfahren zur behandlung von neurodegeneration ATE336246T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US51195200A 2000-02-23 2000-02-23

Publications (1)

Publication Number Publication Date
ATE336246T1 true ATE336246T1 (de) 2006-09-15

Family

ID=24037094

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01906242T ATE336246T1 (de) 2000-02-23 2001-02-23 Verfahren zur behandlung von neurodegeneration

Country Status (20)

Country Link
US (2) US6423739B1 (enExample)
EP (1) EP1171123B1 (enExample)
JP (1) JP2003523385A (enExample)
KR (1) KR20010110798A (enExample)
CN (1) CN1362877A (enExample)
AR (1) AR030551A1 (enExample)
AT (1) ATE336246T1 (enExample)
AU (1) AU784418B2 (enExample)
BR (1) BR0104586A (enExample)
CA (1) CA2368352C (enExample)
DE (1) DE60122252T2 (enExample)
DK (1) DK1171123T3 (enExample)
ES (1) ES2270981T3 (enExample)
HK (1) HK1047038A1 (enExample)
ID (1) ID30377A (enExample)
IL (1) IL145799A (enExample)
MX (1) MXPA01010749A (enExample)
NO (1) NO321911B1 (enExample)
TW (1) TWI289060B (enExample)
WO (1) WO2001062246A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040077709A1 (en) * 1999-05-31 2004-04-22 Daiichi Pharmaceutical Co., Ltd. Neuronal death inhibitors
KR100823668B1 (ko) * 2000-12-28 2008-04-21 해밀턴 파마슈티컬스 인코포레이티드 신경성 통증 치료 및 예방약
ATE404192T1 (de) * 2001-08-22 2008-08-15 Hamilton Pharmaceuticals Inc Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration
RU2205631C1 (ru) * 2002-06-19 2003-06-10 Закрытое акционерное общество "Брынцалов-А" Ноотропное средство "ноотобрил" в форме таблеток
US20060241144A1 (en) * 2005-04-20 2006-10-26 Albert Cha Method for treating apathy syndrome
ES2664727T3 (es) 2009-10-22 2018-04-23 University College Dublin National University Of Ireland, Dublin Terapia causal de enfermedades o estados asociados con desmielinización del SNC o del SNP
RU2480214C1 (ru) * 2011-09-22 2013-04-27 Валентина Ивановна Ахапкина Состав, обладающий модуляторной активностью с соразмерным влиянием, фармацевтическая субстанция (варианты), применение фармацевтической субстанции, фармацевтическая и парафармацевтическая композиция (варианты), способ получения фармацевтических составов

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2469995A (en) * 1946-07-23 1949-05-10 Schaul Martin Carl Process for the production of food preparations from potatoes and similar farinaceoustubers
US3031314A (en) * 1960-03-16 1962-04-24 Carl E Hendel Preparation of dehydrated potatoes
US3260607A (en) * 1961-02-07 1966-07-12 Canadian Patents Dev Preparation of dehydrated cooked mashed potato
US3968265A (en) * 1973-02-01 1976-07-06 American Potato Company Freeze-thaw stable, french fry potato product and process for producing the same
DE2923975A1 (de) 1979-06-13 1980-12-18 Nattermann A & Cie Pyrrolidinone, verfahren zu deren herstellung und diese enthaltende arzneimittel
DE2924011C2 (de) 1979-06-13 1982-04-08 A. Nattermann & Cie GmbH, 5000 Köln Pyrrolidin-(2)-on-(1)-ylessigsäure-2,6,-dimethylanilid, Verfahren zur Herstellung und Arzneimittel, welche diese Verbindung enthalten
IT1141287B (it) 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
SK279285B6 (sk) 1991-05-02 1998-09-09 Daiichi Pharmaceutical Co. Použitie n-(2,6-dimetylfenyl)-2-(2-oxo-1-pyrolidin
US5525058A (en) 1992-03-27 1996-06-11 American Dental Technologies, Inc. Dental treatment system
EP0785599B1 (en) 1995-07-10 2000-12-13 Kodera Electronics Co., Ltd. Device for inserting a wire to be worked on
US6107330A (en) 1995-08-07 2000-08-22 Daiichi Pharmaceutical Co., Ltd. Inhibitor for narcotic analgesic dependence/resistance acquisition
JP2002241272A (ja) 1996-07-18 2002-08-28 Mitsubishi Pharma Corp 医薬処方組成物
NZ333978A (en) 1996-07-30 2000-09-29 Henkel Ecolab Gmbh & Co Film-building agent for protecting teats and udders against infection after milking, comprising a film-forming component and disinfecting agents
KR20000048847A (ko) 1996-10-01 2000-07-25 스즈키 다다시 미토콘드리아 막 안정화제
US6211701B1 (en) 1996-12-16 2001-04-03 Rose Research, Llc Low power line switching circuit, device and method
IT1293533B1 (it) 1997-07-14 1999-03-01 Angeletti P Ist Richerche Bio Metodo per la selezione di molecole in grado di mimare, inibire o potenziare gli effetti della interazione tra leptina e cellule che
AU8131198A (en) 1997-07-15 1999-02-10 Daiichi Pharmaceutical Co., Ltd. Prophylactic or therapeutic agent for amnesia
JPH1180027A (ja) 1997-09-12 1999-03-23 Dai Ichi Seiyaku Co Ltd 向知性薬
TW544311B (en) 1998-08-06 2003-08-01 Daiichi Seiyaku Co Therapeutic or preventive agent for intractable epilepsies
CN1368882A (zh) 1999-05-31 2002-09-11 第一制药株式会社 神经元死亡抑制剂

Also Published As

Publication number Publication date
EP1171123A1 (en) 2002-01-16
US20020055534A1 (en) 2002-05-09
ID30377A (id) 2001-11-29
US6399650B2 (en) 2002-06-04
HK1047038A1 (zh) 2003-02-07
ES2270981T3 (es) 2007-04-16
MXPA01010749A (es) 2002-08-20
CA2368352C (en) 2009-11-10
NO20015162L (no) 2001-12-21
KR20010110798A (ko) 2001-12-13
CA2368352A1 (en) 2001-08-30
DK1171123T3 (da) 2006-12-04
IL145799A0 (en) 2002-07-25
NO20015162D0 (no) 2001-10-22
AU3414501A (en) 2001-09-03
AU784418B2 (en) 2006-03-30
NO321911B1 (no) 2006-07-17
DE60122252T2 (de) 2007-07-05
US20010051653A1 (en) 2001-12-13
DE60122252D1 (de) 2006-09-28
CN1362877A (zh) 2002-08-07
AR030551A1 (es) 2003-08-27
EP1171123B1 (en) 2006-08-16
IL145799A (en) 2006-10-31
BR0104586A (pt) 2002-01-08
WO2001062246A1 (en) 2001-08-30
JP2003523385A (ja) 2003-08-05
TWI289060B (en) 2007-11-01
US6423739B1 (en) 2002-07-23

Similar Documents

Publication Publication Date Title
DE60120520D1 (de) Verfahren zur behandlung von abwasser
DE60122532D1 (de) Verfahren zur behandlung von mehreren bohrlochintervallen
DE69806970D1 (de) Verfahren zur behandlung von hartgeweben
DE60102016D1 (de) Verfahren zur behandlung von beweggungsstörungen
ATE296915T1 (de) Verfahren zur textilbehandlung
DE60045416D1 (de) Verfahren zur behandlung von mikroelektroniksubstraten
DE60138046D1 (de) Verfahren zur reinigung von methanhaltigem abgas
ATE268312T1 (de) Verfahren zur entsalzung von meerwasser
ATE282333T1 (de) Verfahren zum behandeln von tabak
DE60014506D1 (de) Verfahren zur Entfernung von Organohalogenverbindungen
ATA17552001A (de) Verfahren zur behandlung säurehältiger abwässer
DE60216514D1 (de) Verfahren zur behandlung von dämpferkondensat
DE60125906D1 (de) Verfahren zur Verbesserung von Leistung
EP1353933A4 (en) METHOD FOR PURIFYING LACTOSE
DE50113292D1 (de) Verfahren zur abreicherung von endotoxinen
EP1200538A4 (en) PROCESS FOR TREATING OIL ACIDS
ATE321832T1 (de) Verfahren zur aufbereitung von oliven
DE60133996D1 (de) Kosmetisches VERFAHREN ZUR BEHANDLUNG VON Celluliten
DE50113263D1 (de) Verfahren zur Anpassung von Aromamischungen
ATE307871T1 (de) Verfahren zur behandlung von gewebe
DE60122252D1 (de) Verfahren zur behandlung von neurodegeneration
DE50001116D1 (de) Verfahren zur justage von parabolantennen
ATE483848T1 (de) Verfahren zur behandlung von cellulosischen formkörpern
ATA15252000A (de) Verfahren zur dekontamination
ATE321748T1 (de) Verfahren zur fluormethylierung von alkoholen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1171123

Country of ref document: EP

REN Ceased due to non-payment of the annual fee